CD34 and neoplasm: Together, the mIHC, scRNA-seq, and spatial transcriptomic data reveal that tumor regions are not only highly enriched with CD34+ tumor endothelial cells, but also have VEGFA+ PVM that interact with these endothelial cells in that region.